We are live on ! Find out more
DCM

Dinsmore Capital Management Portfolio holdings

AUM $230M
1-Year Est. Return 0.29%
This Fund
S&P 500
This Quarter Est. Return
+0.26%
1 Year Est. Return
-0.29%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$228M
AUM Growth
Cap. Flow
+$76.4M
Cap. Flow %
33.57%
Top 10 Hldgs %
17.13%
Holding
120
New
38
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Communication Services 2.83%
2 Healthcare 2.51%
3 Technology 0.93%
4 Financials 0.82%
5 Energy 0.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
26
Bristol-Myers Squibb
BMY
$129B
$894K 0.39%
+20,000
New +$868K
ABBV icon
27
AbbVie
ABBV
$465B
$827K 0.36%
+20,000
New +$875K
LLY icon
28
Eli Lilly
LLY
$1.08T
$737K 0.32%
+15,000
New +$816K
ABT icon
29
Abbott
ABT
$187B
$628K 0.28%
+18,000
New +$660K
INTC icon
30
Intel
INTC
$413B
$606K 0.27%
+25,000
New +$591K

Similar funds

Dinsmore Capital Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Dinsmore Capital Management, which disclosed 120 positions worth $228M. Its ten largest holdings account for 17% of the portfolio.

Its largest position is Wells Fargo 7.5% Non Cumv Perp Conv: 4,000 shares worth $4.78M.

By sector, the portfolio is most concentrated in Communication Services at 2.8% of assets, followed by Healthcare and Technology.

  • Dinsmore Capital Management's largest Q2 2013 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 4,000 shares worth $4.78M.
  • Dinsmore Capital Management's ten largest holdings make up 17% of its $228M portfolio in Q2 2013.
  • Dinsmore Capital Management disclosed 120 positions in Q2 2013, its first 13F filing on record.

Based on Dinsmore Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.